What question did this study set out to answer?

To evaluate the clinical challenges, risks, and evidence surrounding the expansion of transcatheter aortic valve implantation to lower-risk surgical cohorts.

September 1, 2016EuroIntervention

Patient selection for TAVI in 2016: should we break through the low-risk barrier?

View Full Paper

Ask AI

Bookmark

Why the study?

Should TAVI indications be expanded to lower-risk patients?

Key Points

To evaluate the clinical challenges, risks, and evidence surrounding the expansion of transcatheter aortic valve implantation to lower-risk surgical cohorts.
Narrative synthesis of early and late clinical outcomes following transcatheter aortic valve implantation versus surgical aortic valve replacement.
Evaluation of prosthetic valve durability, hemodynamic maintenance, procedural refinements, and complication rates.
Transcatheter approaches offer lower invasiveness and fewer early devastating postoperative complications than conventional surgery in high-risk patients.
Extending transcatheter treatment to lower-risk patients requires confirming long-term hemodynamic durability and clinical efficacy alongside continuous procedural refinement.

Structured PICO

Should TAVI indications be expanded to lower-risk patients?

Population

Patients considered for transcatheter aortic valve implantation (TAVI), specifically discussing the expansion to lower-risk patients

Intervention

Transcatheter aortic valve implantation (TAVI)

Comparator

Surgical aortic valve replacement (SAVR) or conservative therapy

This review discusses the clinical considerations, including valve durability and procedural complications, for expanding TAVI indications to lower-risk patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Durability and complication concerns warrant caution before TAVI expansion to lower-risk patients; leaves open need for long-term randomized data.

Cite This Study

Abdelghani et al. (2016) studied this question.

synapsesocial.com/papers/6a87f1453c898f1314eb3085 https://doi.org/10.4244/eijv12sya11

Topics

Transcatheter aortic valve replacement TAVR in low-risk patients

View Full Paper

Ask AI

Bookmark

Implication

Durability and complication concerns warrant caution before TAVI expansion to lower-risk patients; leaves open need for long-term randomized data.

Patient selection for TAVI in 2016: should we break through the low-risk barrier?

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Topics

Patient selection for TAVI in 2016: should we break through the low-risk barrier?

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider